Cargando…
Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
Among hematological cancers, Acute Lymphoblastic Leukemia (ALL) and Chronic Lymphocytic Leukemia (CLL) are the most common leukemia in children and elderly people respectively. Some patients do not respond to chemotherapy treatments and it is necessary to complement it with immunotherapy-based treat...
Autores principales: | Herrera, L., Santos, S., Vesga, M. A., Anguita, J., Martin-Ruiz, I., Carrascosa, T., Juan, M., Eguizabal, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904575/ https://www.ncbi.nlm.nih.gov/pubmed/31822751 http://dx.doi.org/10.1038/s41598-019-55239-y |
Ejemplares similares
-
The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Herrera, Lara, et al.
Publicado: (2021) -
Umbilical cord blood: A promising source for allogeneic CAR-T cells
por: Liu, Dian-Dian, et al.
Publicado: (2022) -
Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells
por: Caël, Blandine, et al.
Publicado: (2022) -
OP9 Feeder Cells Are Superior to M2-10B4 Cells for the Generation of Mature and Functional Natural Killer Cells from Umbilical Cord Hematopoietic Progenitors
por: Herrera, Lara, et al.
Publicado: (2017) -
Good practices in collecting umbilical cord and placental blood
por: Lopes, Lauren Auer, et al.
Publicado: (2016)